4.2 Article

Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency

Journal

RETROVIROLOGY
Volume 16, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12977-019-0494-x

Keywords

HIV-1; Transcription; Latency; Latent infection

Categories

Funding

  1. U.S. Department of Veterans Affairs [IK2 CX000520, I01 BX000192]
  2. National Institute of Diabetes and Digestive and Kidney Diseases at the NIH [R01DK108349, R01DK120387]
  3. National Institute of Allergy and Infectious Diseases at the NIH [R01AI132128, R56AI116342, R33AI116218, R56AI091573, U19AI096109]
  4. American Foundation for AIDS Research (amfAR) Institute for HIV Cure Research [109301]
  5. CFAR Mentored Scientist Award in HIV/AIDS
  6. UCSF/Gladstone Institute of Virology & Immunology CFAR [P30 AI027763]
  7. Delaney AIDS Research Enterprise (DARE) [A127966]
  8. amfAR Institute for HIV Cure Research [amfAR 109301]

Ask authors/readers for more resources

Background HIV-infected cell lines are widely used to study latent HIV infection, which is considered the main barrier to HIV cure. We hypothesized that these cell lines differ from each other and from cells from HIV-infected individuals in the mechanisms underlying latency. Results To quantify the degree to which HIV expression is inhibited by blocks at different stages of HIV transcription, we employed a recently-described panel of RT-ddPCR assays to measure levels of 7 HIV transcripts (read-through, initiated, 5 ' elongated, mid-transcribed/unspliced [Pol], distal-transcribed [Nef], polyadenylated, and multiply-sliced [Tat-Rev]) in bulk populations of latently-infected (U1, ACH-2, J-Lat) and productively-infected (8E5, activated J-Lat) cell lines. To assess single-cell variation and investigate cellular genes associated with HIV transcriptional blocks, we developed a novel multiplex qPCR panel and quantified single cell levels of 7 HIV targets and 89 cellular transcripts in latently- and productively-infected cell lines. The bulk cell HIV transcription profile differed dramatically between cell lines and cells from ART-suppressed individuals. Compared to cells from ART-suppressed individuals, latent cell lines showed lower levels of HIV transcriptional initiation and higher levels of polyadenylation and splicing. ACH-2 and J-Lat cells showed different forms of transcriptional interference, while U1 cells showed a block to elongation. Single-cell studies revealed marked variation between/within cell lines in expression of HIV transcripts, T cell phenotypic markers, antiviral factors, and genes implicated in latency. Expression of multiply-spliced HIV Tat-Rev was associated with expression of cellular genes involved in activation, tissue retention, T cell transcription, and apoptosis/survival. Conclusions HIV-infected cell lines differ from each other and from cells from ART-treated individuals in the mechanisms governing latent HIV infection. These differences in viral and cellular gene expression must be considered when gauging the suitability of a given cell line for future research on HIV. At the same time, some features were shared across cell lines, such as low expression of antiviral defense genes and a relationship between productive infection and genes involved in survival. These features may contribute to HIV latency or persistence in vivo, and deserve further study using novel single cell assays such as those described in this manuscript.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available